Abstract
Introduction There are now well-established global standards for supporting improvement in women’s experience of maternity services, including frameworks for the prevention of mistreatment during childbirth. Given the ongoing reports from Timor-Leste outlining poor quality of care in maternal health services and the low use of health facilities for birth, we aimed to examine the adoption of global respectful maternity care standards in intrapartum care policies in Timor-Leste.
Methods From May to July 2022, we conducted a desk review of the Timor-Leste National Intrapartum Care Standards and Clinical Protocols for Referral Facilities and Community Health Centres. This was followed by a health-facility audit of policies, guidelines and procedures in three main maternity facilities in the capital, Dili to examine the extent to which the WHO (2016) standards for women’s experiences of care have been adopted.
Results Despite the availability of global guidelines, key standards to improve women’s experience of care have been omitted from the National Intrapartum Care guidelines in Timor-Leste. There was no mention of avoiding mistreatment of women, needing informed consent for procedures, or strengthening women’s own capability and confidence. In the policy wording, women tended to be distanced from the care ‘procedures’ and their involvement was framed around being told what to do during the birth process. The results of the health facility assessment showed extremely low use of standards that improve women’s experiences of care. Health Facility 1 and 2 met two of the 21 quality measures, while Health Facility 3 met none of them.
Conclusion The discourse communicated through policy fundamentally affects how health care issues are framed and how policies are enacted. Given the findings of this study, combined with the widespread documentation of poor quality of care, low satisfaction with maternal health services, and emerging stories of physical and verbal abuse of women during birth, there is a need for a fundamental shift in the culture of care for women in Timor-Leste. This will require an immediate focus on leadership, training and policy-frameworks to stop mistreatment of women in health facilities. It will also require a longer-term focus on addressing the power imbalances that drive disrespect and abuse of women within and across social systems, and understanding how to support relationship-based models of care that inherently foster understanding and compassion.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
This research was funded through AF’s PhD scholarship by Airlangga University, Indonesia and Instituto Superior Cristal, Timor-Leste.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from the Ethical Review Committee at Airlangga University, Indonesia (ID# 071/HRECC.FODM/III/2022). Reciprocal approval was obtained from Timor-Leste’s Human Ethics Committee at the National Institute for Health (INS – Instituto Nasional Saude) in Dili (ID# 603MS-INS/GDE/IV/2022).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.